QIAGEN Digital Insights was established in 2014, based on the acquisitions of Ingenuity, CLC bio, and BIOBASE.
Today, the three legacy companies are joined by OmicSoft and N-of-One, working closely together to help our users innovate, integrate and translate basic discoveries into clinical care.
A software platform for life science researchers to explore, interpret and analyze complex biological systems.
Ingenuity Systems offers Knowledge Base and interpretation software applications that enable users to accurately interpret the meaning of increasingly large amounts of biological data to better guide scientific experiments and provide clinically-relevant insights into disease.
The leading bioinformatics analysis and visualization platform
ClC bio provides a wide range of software and cross-platform solutions to support your analysis needs, effectively giving you a one-stop-shop, no matter what the challenge.
QIAGEN CLC Genomics Workbench | QIAGEN CLC Assembly Cell | QIAGEN Main Workbench | QIAGEN Genome Finishing Module | QIAGEN Microbial Genomics Module | QIAGEN CLC Genomics Cloud Server | CLC Server Command Line Tools | QIAGEN CLC Genomics Cloud Engine
Comprehensive database solutions for life science researchers
BIOBASE databases contain unique, manually-curated data from peer-reviewed literature which our analysis tools leverage in order to bring meaning to, and generate maximum value from, your experimental data.
Large-scale ‘omics data management, visualization and analysis solutions
Omicsoft has thousands of users around the world from pharmaceutical and biotech companies, universities, hospitals and research institutes. We are proud to help our users to research disease causes, discover drugs for genetic diseases, understand human genome and create a healthier world.
Curated, high-quality, and actionable clinical interpretation of molecular tests
N-of-One provides expert-powered clinical interpretation solutions combine the insights of oncology experts with proprietary technology and an extensive knowledgebase to provide high-quality, actionable, patient-specific treatment options, supported by the latest clinical evidence and delivered directly to the clinician at the point-of-care.